Addition of low‐dose decitabine to bortezomib and dexamethasone as second‐line therapy in multiple myeloma. (28th April 2020) - Li, Ning; Liu, Lina; Xiang, Pu; Liang, Lijie; Wang, Juan; Wang, Yaomei; Luo, Suxia; Song, Yongping; Fang, Baijun